The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial

Collapse authors list.
Wiviott, Stephen D, Raz, Itamar, Bonaca, Marc P, Mosenzon, Ofri, Kato, Eri T, Cahn, Avivit, Silverman, Michael G, Bansilal, Sameer, Bhatt, Deepak L, Leiter, Lawrence A et al (show 6 more authors) , McGuire, Darren K, Wilding, John PH ORCID: 0000-0003-2839-8404, Gause-Nilsson, Ingrid AM, Langkilde, Anna Maria, Johansson, Peter A and Sabatine, Marc S (2018) The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)-TIMI 58 Trial. AMERICAN HEART JOURNAL, 200. 83 - 89.

Text DECLARE_Design_Paper_Re Submission - 12-7-17 CLEAN.docx - Accepted Version Download (344kB)